|

KUP-101A Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Kupando GmbH1

Indications

  • Merkel Cell Carcinoma of Skin1
  • Basal Cell Carcinoma of Skin1
  • Mucosal Melanoma1
  • Cutaneous Squamous Cell Carcinoma (CSCC)1
  • Cutaneous Melanoma1

Other1 trial

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.